Hematological malignancies can present with severe complications, including hyperleukocytosis, which demands immediate intervention due to elevated leukocyte counts that increase blood viscosity and cause microcirculatory abnormalities. This case report highlights the critical role of therapeutic leukapheresis in managing a pediatric patient with acute myeloid leukemia (AML) in crisis. A six-year-old male child presented with symptoms of severe hyperleukocytosis, including high-grade fever, respiratory distress, and a significant leukocyte count (555,820/µL). Immediate interventions included intravenous hydration, antibiotics, steroids, and non-invasive ventilation, followed by therapeutic leukapheresis. The leukapheresis procedure successfully reduced the leukocyte count by 81% without any adverse events. Post-procedure treatment with etoposide further decreased the leukocyte count, leading to symptomatic improvement and stabilization of the patient. The patient was later discharged in stable condition and continued receiving induction-phase chemotherapy. This case underscores the efficacy and necessity of leukapheresis as a life-saving adjunctive therapy in pediatric AML crises, demonstrating its role in rapidly reducing leukocyte counts and preventing life-threatening complications.
Keywords: acute myeloid leukemia; hyperleukocytosis; leukapheresis; leukostasis; tumor lysis syndrome.
Copyright © 2024, V et al.